PMA
INSP icon

Prudent Man Advisors’s Inspire Medical Systems INSP Stock Holding History

Prudent Man Advisors’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-855
Closed -$278K – 206
2023
Q2 		$278K Hold
855
– – 0.1% 148
2023
Q1 		$200K Hold
855
– – 0.08% 187
2022
Q4 		$215K Buy
+855
New +$182K 0.09% 178
2022
Q2 		– Sell
-823
Closed -$211K – 178
2022
Q1 		$211K Buy
+823
New +$188K 0.09% 172

Other funds holding INSP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Prudent Man Advisors's INSP Position: Q3 2023 in Review

Prudent Man Advisors sold out of Inspire Medical Systems (INSP) in Q3 2023, closing a stake of 855 shares — an estimated $278K sold.

Prudent Man Advisors first reported a position in INSP in Q1 2022 and held it in 4 quarters. The position peaked at $278K in Q2 2023. 364 funds tracked by Wall St. Rank hold INSP as of Q3 2023.

  • Prudent Man Advisors reported no remaining Inspire Medical Systems position as of Q3 2023 after selling out during the quarter.
  • Prudent Man Advisors sold 855 Inspire Medical Systems shares in Q3 2023, an estimated $278K.
  • Prudent Man Advisors first reported a position in Inspire Medical Systems in Q1 2022 and held it in 4 quarters.
  • Prudent Man Advisors's Inspire Medical Systems position peaked at $278K in Q2 2023.
  • 364 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2023.

Based on Prudent Man Advisors's 13F filing for Q3 2023, filed 9 Nov 2023.